GlassScriptPhysician profile
Andrew Kapsalis
NPI 1780093765
$37,458.35
in general payments reported to CMS, 2019-2025
34 companies · $1,724 in 2025
The $1,724 reported for 2025 was more than what 88% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,710 · 2020: $1,647 · 2021: $3,044 · 2022: $1,417 · 2023: $15K · 2024: $13K · 2025: $1,724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $2,917 · Food and Beverage: $2,803 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,375.00 |
| Travel and Lodging | $2,916.82 |
| Food and Beverage | $2,803.04 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $545.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fusion Orthopedics USA, LLC | $20,206.32 | 2023-2025 | Minilock |
| Summ Cott Medical | $4,950.00 | 2019-2024 | |
| Biopoly LLC | $3,270.00 | 2023-2024 | |
| Crossroads Orthopedics, LLC | $2,695.29 | 2019-2020 | |
| Trilliant Surgical LLC. | $1,998.45 | 2022-2024 | Arsenal Sinus Support Plate, Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Paragon 28, INC. | $1,305.61 | 2019-2022 | |
| Fusion Orthopedics, LLC. | $799.98 | 2023 | |
| Stryker Corporation | $748.33 | 2019-2025 | Inbone, Augment Injectable, Infinity |
| Medshape, INC. | $223.79 | 2023-2025 | Dynanail Helix, Washer, 15 Mm, Dynanail |
| Flower Orthopedics Coporation | $149.44 | 2022 | |
| Depuy Synthes Sales INC. | $129.17 | 2020-2023 | Quickanchor Orthocord, Motoband |
| Novastep INC. | $126.45 | 2025 | Nexis |
| Smith+Nephew, INC. | $114.40 | 2020-2025 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Kerecis Limited | $113.73 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $65.17 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $60.75 | 2024 | |
| Orthofix Medical, INC. | $58.27 | 2022-2025 | Physio-Stim |
| Treace Medical Concepts, INC. | $56.13 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.39 | 2019 | |
| Paratek Pharmaceuticals, INC. | $47.05 | 2024-2025 | Nuzyra |
| Cardiovascular Systems INC. | $38.65 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $32.35 | 2024-2025 | |
| Djo, LLC | $29.28 | 2019-2022 | |
| Horizon Therapeutics Plc | $29.03 | 2019 | |
| Alafair Biosciences, INC. | $27.88 | 2022 | |
| Zimmer Biomet Holdings, INC. | $27.34 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $24.68 | 2019 | |
| Medtronic, INC. | $18.56 | 2024 | Intellis Adaptivestim |
| Access Pro Medical, LLC | $15.35 | 2025 | Matriderm |
| Organogenesis INC. | $14.28 | 2024 | |
| Kci USA, INC. | $13.39 | 2020 | |
| In2bones USA, LLC | $10.99 | 2021 | |
| Arthrosurface Incorporated | $10.85 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$26,683.20 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kapsalis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.